Ketamine for the Treatment for Alcohol Use Disorder in the ED
Status:
Not yet recruiting
Trial end date:
2024-08-30
Target enrollment:
Participant gender:
Summary
The investigators' approach is to conduct a pilot double-blind, placebo-controlled randomized
clinical trial with individuals with alcohol use disorder (AUD) seeking inpatient alcohol
detoxification in the emergency department (ED) to receive either intravenous ketamine or
saline placebo. The primary aim is to evaluate the intervention's safety. The secondary aim
is to evaluate the preliminary efficacy of alcohol-related outcomes.
Phase:
Phase 2
Details
Lead Sponsor:
Brigham and Women's Hospital
Collaborator:
National Institute on Alcohol Abuse and Alcoholism (NIAAA)